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Abstract
The ventromedial medulla (VM), subdivided in a rostral (RVM) and a caudal (CVM) part, has a powerful influence on the
spinal cord. In this study, we have identified the distribution of glycine and GABA containing neurons in the VM with
projections to the cervical spinal cord, the lumbar dorsal horn, and the lumbar ventral horn. For this purpose, we have
combined retrograde tracing using fluorescent microspheres with fluorescent in situ hybridization (FISH) for glycine
transporter 2 (GlyT2) and GAD67 mRNAs to identify glycinergic and/or GABAergic (Gly/GABA) neurons. Since the results
obtained with FISH for GlyT2, GAD67, or GlyT2+GAD67 mRNAs were not significantly different, we concluded that glycine
and GABA coexisted in the various projection neurons. After injections in the cervical cord, we found that 29%61 (SEM) of
the retrogradely labeled neurons in the VM were Gly/GABA (RVM: 43%; CVM: 21%). After lumbar dorsal horn injections
31%63 of the VM neurons were Gly/GABA (RVM: 45%; CVM: 12%), and after lumbar ventral horn injections 25%62 were
Gly/GABA (RVM: 35%; CVM: 17%). In addition, we have identified a novel ascending Gly/GABA pathway originating from
neurons in the area around the central canal (CC) throughout the spinal cord and projecting to the RVM, emphasizing the
interaction between the ventromedial medulla and the spinal cord. The present study has now firmly established that GABA
and glycine are present in many VM neurons that project to the spinal cord. These neurons strongly influence spinal
processing, most notably the inhibition of nociceptive transmission.
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Introduction
There are extensive projections from the ventromedial medulla
(VM) to the spinal cord, which reach both the dorsal and ventral
horns. While in the cat the rostral VM (RVM) projects
preferentially to the dorsal horn and the caudal VM (CVM) to
the ventral horn, this segregation is less clear in the rat [1,2]. With
respect to the dorsal horn, attention has mainly focused on the role
of the RVM in spinal nociception. The RVM, which includes the
midline nucleus raphe magnus (RM) and the adjacent reticular
formation, is under strong control of the periaqueductal grey
(PAG), which produces analgesic effects through the RVM [3].
However, the RVM not only produces inhibition but also
facilitation of spinal nociception [4–6], which may result in
hyperalgesia and allodynia as observed in inflammatory and
neuropathic pain models [7]. These findings suggest that there are
specific subsets of RVM projection neurons that either inhibit or
facilitate spinal nociception. Indeed, electrophysiological studies
have shown that so-called ON-cells in the RVM have a net
facilitatory effect on nociception, while a second group, designated
as OFF-cells, has a net inhibitory effect on nociception [4,8]. For a
long time it was believed that serotonin was responsible for
inhibiting spinal nociception [9–12] and therefore the most likely
transmitter in the OFF cells. However, serotonin was never found
in ON- or OFF-cells [13,14], therefore the neurotransmitters used
by the ON- and OFF-cells remain unidentified [4,5]. Tracing
studies, combined with immunohistochemistry for GABA or
glutamate decarboxylase (GAD) have shown the existence of
GABAergic projections to the dorsal horn [15–18] and the ventral
horn [19,20]. However, up to now, the distribution pattern of
these spinally projecting GABAergic neuronal somata in the RVM
has not been investigated in detail and the location of glycinergic
RVM neurons with spinal projections is still unknown.
In order for the RVM to change its activation pattern in
response to nociceptive stimuli, it must receive information from
the spinal cord [4,8,21,22]. However, anatomical data on direct
projections from the spinal cord to the RVM are scarce, and it is
assumed that the RVM receives most information from the spinal
cord indirectly by projections from the PAG, or lateral
paragigantocellular reticular nucleus (LPGi) [23–26]. Spinal
neurons that project directly to the RVM are found mainly
around the central canal [27], of which some contain the
neuropeptide enkephalin [28].
In the present study, we have combined retrograde tracing with
in situ hybridization for glycine transporter 2 (GlyT2) and GAD67
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mRNA to determine the distribution pattern of glycine and/or
GABA (Gly/GABA) containing neurons in the VM that project to
the cervical and lumbar spinal cord. We found that a substantial
percentage of VM neurons that project to the spinal cord contain
both GABA and glycine. In addition, we found a novel ascending
pathway that contains GABA and glycine. This pathway originates
from the area around the central canal throughout the spinal cord,
and projects to the RVM.
Materials and Methods
In this study, we used a total of 43 male Wistar rats between
250–300 grams. All animal experiments were approved by the
Rotterdam Animal Ethical Committee.
Tracer Injections
We used FluoSpheres (0.04 mm; molecular Probes, Eugene,
OR), consisting of fluorescent polystyrene microspheres for
retrograde tracing. For tracer injections in the spinal cord and
the brainstem, the rats were kept under general anesthesia with
2% isofluoran in 30%O2/70%N2O. For injections, a glass
micropipette was used, and with each injection between 80 to
100 nanoliter (nl) of tracer was injected using an air pressure
device. Further, after each injection the micropipette was left
untouched for a period of 3 minutes in order to avoid regurgitation
of the injected volume. All injections were made in the left side of
the spinal grey matter, or in the midline, left side or both sides of
the brainstem. After the operation, the animals were returned to
standard housing for a period of 25–28 days.
Spinal Cord Injections
For identifying neurons in the RVM that project to the spinal
cord, microspheres were injected in the lumbar or cervical
enlargement. First, laminectomy was performed at L4–L6 levels
(lumbar injections) or at C4–C6 levels (cervical injections) of the
spinal cord, producing an open area of approximately 3 mm with
a visible dura mater. Next, the animal was fixed using stereotaxic
instruments, and the posterior spinal vein was taken as the
reference for the midline. In the lumbar spinal cord, injections
were made between 0.7 and 0.9 mm lateral to the midline, and in
the cervical spinal cord injections were made between 0.5 and
1.5 mm lateral to the midline. For injections in the lumbar dorsal
horn (n= 7), the spinal cord was approached dorsally at an angle
of 45u, and between 3 to 5 injections were made at 0.5 and
0.9 mm below the surface of the spinal cord. For injections in the
ventral horn (n= 5), the spinal cord was approached laterally at an
angle of 30u, and between 3 to 5 injections were made at depths of
1.2 and 1.7 mm below the surface of the spinal cord. In the
cervical spinal cord (n= 5), we did not differentiate between the
dorsal and the ventral horn, and therefore the injections were
made at different depths ranging between 0.5 and 1.5 mm.
Brainstem Injections
Brainstem injections were made in the rostral ventromedial
medulla (RVM), encompassing the raphe magnus (RM), gigan-
tocellular reticular nucleus (Gi) and lateral paragigantocellular
reticular nuclei (LPGi) (n = 6). For operation, the caudal part of the
skull was removed and the caudal end of obex was identified. The
injections were made at61.6 mm rostral to the obex and were
limited to the midline (n = 2), between 0.4 and 1.0 mm lateral to
the midline on one side (n = 2), or on both sides (n = 2). All
injections were made at depths between 4.5 and 5.0 mm below the
level of the obex.
Tissue Preparation
After survival periods of 25–28 days, the rats received an
overdose of sodium pentobarbital, and were then transcardially
perfused with 150 ml saline followed by 750 ml of 4%
paraformaldehyde (PFA) in phosphate buffer (PB, pH 7.4).
Thereafter, the spinal cord and the brainstem were dissected
and incubated overnight at 4uC in RNAse free solution consisting
of 4% PFA and 30% sucrose in PB. Coronal sections were cut at
30 mm with a freezing microtome, collected in 9 separate jars and
stored in a solution consisting of RNAse free PB and formamide
(50%/50%) at –20uC. We did not use glycerol for storage, since it
appeared to reduce the fluorescence intensity of the beads over
time. This was not observed when sections were stored in PB/
formamide solution.
Fluorescent in Situ Hybridization
Fluorescent in situ hybridization (FISH) was performed using
the protocol described previously [29,30]. We used cDNA
templates (GlyT2 cDNA: 3.1 kb; a generous gift from Dr. N.
Nelson, Tel Aviv University; GAD67 cDNA: 3.2 kb; a generous
gift from Dr. A.J. Tobin and N. Tillakaratne, PhD, UCLA) to
produce the GlyT2 and GAD67 mRNA probes in the presence of
Digoxigenin-labeled 11-UTP. After riboprobe hybridization, we
applied immunohistochemistry (IHC) with a sheep anti-digox-
igenin polyclonal antibody (Roche) to identify digoxigenin (4uC,
48hrs). Subsequently, the primary antibody was identified with
biotinylated rabbit-anti-goat antibody (Vector) (room temperature
(RT), 90 min), followed by incubation with Avidin Biotin Complex
(ABC) tagged with horseradish peroxidase (HRP) (RT, 90 min).
Thereafter, a tyramide amplification procedure was performed by
reacting HRP with H2O2 and a self-made FITC tyramide as
described previously [31]. Finally, sections were washed in PB,
randomly mounted on slides and coverslipped with Vectashield
(Vector).
Analyzing labeled Neurons
In rats with tracer injections in the cervical or lumbar spinal
cord, sections from the caudal medulla at three levels that included
the inferior olive (Oi) nucleus (2–3 sections per level), and sections
at three levels ranging from caudal to rostral RVM were analyzed
(2–3 sections per level). In rats with tracer injections in the RVM,
we analyzed sections from the cervical, upper and lower parts of
the thoracic, lumbar and sacral segments. Sections for analysis
were chosen by starting in the first row of the randomly mounted
sections and searching for sections from the appropriate segmental
level (C4 to T5 for cervical and upper thoracic segments; T10 to
S4 for lower thoracic, lumbar and sacral segments). Per rat, 10–12
sections for cervical and upper thoracic segments, and 12–14
sections for lower thoracic, lumbar and sacral segments were
analyzed in a Leica fluorescent microscope with a FITC and/or
Cy3 filter.
In order to investigate colocalization of the FluoSpheres beads
(apparent as red particles using a Cy3 filter) with GlyT2/GAD67
mRNAs (FITC) staining, first labeling for the tracer (red particles)
was determined in a 40x objective. A neuron was counted as
positive for tracer labeling if at least ten bright red particles were
present in the soma. Then, in the same focus field, we determined
whether there was labeling for GlyT2/GAD67 mRNAs present in
the cytoplasm. If in the same focus field, tracer labeling was
present together with somatic GlyT2/GAD67 mRNAs staining,
the neuron was counted as a double-labeled neuron. Single tracer
labeled neurons and tracer labeled neurons that contained GlyT2/
GAD67 were plotted by hand in an illustrated representation of
the appropriate segmental level. In the illustrations used for spinal
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cord sections, the grey matter was divided in 3 areas (area 1:
laminae I and II; area 2: laminae III-VI; area 3: laminae VII-X)
according to the laminar distribution in the rat [32,33]. For
brainstem sections, we used illustrations of brainstem sections
according to the rat brain atlas [34]. Per rat, the number of
neurons labeled with tracer only, with tracer/GlyT2, tracer/
GAD67 or tracer/GlyT2/GAD67 was determined for the RVM,
the CVM or the different spinal cord areas, and for each area the
percentages of tracer labeled neurons that were double labeled
were calculated. The results obtained per rat for each of the
Figure 1. Neurons in the ventromedial medulla that were retrogradely labeled from the spinal cord and neurons labeled for GlyT2
and/or GAD67 mRNAs. Fluorescence micrographs (A1, B1) and their magnifications (A2, B2) showing neurons in the rostral ventromedial medulla
(RVM) retrogradely labeled with fluorescent microspheres (red) from the lumbar (L4) dorsal horn (A) and the cervical (C5) spinal cord (B), and neurons
labeled for GlyT2 and/or GAD67 mRNAs (Gly/GABA neurons, green) using fluorescent in situ hybridization (FISH). Arrowheads indicate Gly/GABA
neurons that are also retrogradely labeled from the spinal cord. Note that the fluorescent microspheres and the labeling for Gly/GAD67 mRNA are
located in the cytoplasm, outside of the neuronal nuclei. The intensity of the fluorescent labeling varied between the labeled neurons, several of
which are also out of focus. Gi: gigantocellular reticular nucleus, alpha part (GiA); LPGi: lateral paragigantocellular reticular nucleus, alpha part (LPGiA),
external part (LPGiE); Ml: medial lemniscus; RMg: raphe magnus nucleus. Scale bar: 50 mm.
doi:10.1371/journal.pone.0035293.g001
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various areas and injection sites were averaged. Errors in the
variations were assessed as standard error of the mean (SEM). The
unpaired t-test or one-way ANOVA with a Bonferroni post-hoc
test was performed for the various statistical comparisons and
p,0.05 was taken as significant.
Results
General Observations
Inhibitory neurons, i.e. neurons that use either glycine or GABA
or both transmitters, were labeled by means of fluorescent in situ
hybridization (FISH). We used FISH with probes for GlyT2
mRNA (for identifying glycinergic neurons), or GAD67 mRNA
(for identifying GABAergic neurons), or with a mixture of probes
for GlyT2 and GAD67 mRNAs (GlyT2/GAD67) for identifying
glycinergic and/or GABAergic (Gly/GABA) neurons (Fig. 1).
FISH was applied on sections from the brainstem and the spinal
cord, resulting in greenish-labeled neuronal somata of various
sizes. The distribution patterns of the labeled neurons, i.e.
glycinergic and/or GABAergic, in the spinal cord and the
brainstem were in general accordance with previous findings
[35–38].
After injection of fluorescent microspheres in the spinal cord
and brainstem, we found retrogradely labeled neurons of various
sizes in the brainstem and spinal cord, respectively. The
retrogradely labeled neurons contained bright red particles, which
represented the retrogradely transported microspheres, which
were present in the somata and primary dendrites of the labeled
neurons (Fig. 1). The number of red particles varied considerably
between the labeled neurons.
Neurons in the Ventromedial Medulla Retrogradely
Labeled from the Spinal Cord
Injection sites. In the cervical spinal cord, several injections
with fluorescent microspheres were made unilaterally at the C5–
C6 level. The injections included nearly the entire grey matter and
parts of the adjoining white matter (Fig. 2A). For injections in the
lumbar spinal cord, we injected fluorescent microspheres in the
dorsal or the ventral horn of the lumbar segments L4–L6. With
respect to the dorsal horn (Fig. 2B), injection sites included
laminae I to VI, and in some cases the dorsal and/or lateral parts
of the white matter. The injections in the ventral horn (Fig. 2C)
included laminae VII to IX, and parts of the lateral and ventral
white matter. Since the latter injections were made using a lateral
approach, they never included any part of the dorsal horn or its
adjacent white matter.
Overview of the results. We analyzed the distribution of
retrogradely labeled neurons in the ventromedial medulla, which
consists of the rostral ventromedial medulla (RVM) and the caudal
ventromedial medulla (CVM). The RVM includes the nucleus
raphe magnus (RM), raphe pallidus (RP), gigantocellular reticular
nucleus (Gi), part alpha of Gi nucleus (GiA), part alpha of lateral
Figure 2. The injection sites of fluorescent microspheres in the rat spinal cord. Drawings illustrating fluorescent microsphere injection sites
in the dorsal and ventral cervical (C5–C6) spinal cord (A), in the dorsal horn (laminae I to VI) (B) and in the ventral horn (laminae VII-X) (C) of the
lumbar (L4–L6) spinal cord. Note that all injections were confined to one side, and that in some cases fluorescent tracer was also present the adjacent
white matter. Roman figures indicate spinal laminae.
doi:10.1371/journal.pone.0035293.g002
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paragigantocellular (LPGi) nucleus (LPGiA), and the external part
of LPGi nucleus (LPGiE). The CVM includes the RP, raphe
obscurus (ROb), the ventral part of the medullary reticular nucleus
(MdV), Gi nucleus, the ventral part of Gi (GiV), and LPGi
nucleus, at levels ranging from the most caudal to the most rostral
part of the olivary inferior nucleus (Oi). We first determined, for
each of the injection sites, the overall percentages of retrogradely
labeled neurons in the ventromedial medulla that were also labeled
for GlyT2 and/or GAD67 mRNA (Gly/GABA neurons). After
injections in the cervical spinal cord 29%61 (SEM) of the
retrogradely labeled neurons were Gly/GABA. After injections in
the lumbar dorsal horn and ventral horn (Fig. 3), these percentages
were 31%63 and 25%62, respectively. We found no significant
differences in the percentages between neurons retrogradely
labeled from cervical, lumbar dorsal and ventral horns. In the
next sections, the results are presented in more detail.
Neurons in the ventromedial medulla retrogradely
labeled from the cervical spinal cord. After injections in
the C5-C6 spinal cord, which encompassed most of the dorsal and
ventral horns, a total of 3257 retrogradely labeled neurons was
analyzed for the RVM and CVM separately (Fig. 4A, B). Most
retrogradely labeled neurons were found on the side ipsilateral to
the injection (RVM: 87%63; CVM: 75%62). The percentages of
retrogradely labeled neurons (ipsi+contra) that contained GlyT2,
GAD67, or GlyT2/GAD67 mRNA are shown in Fig. 5A. These
percentages were always significantly lower in the CVM than in
the RVM (p,0.005, ANOVA). Within the RVM and the CVM
there were no significant differences between the various
percentages (p.0.1, ANOVA, Fig. 5A) nor between the
ipsilateral and contralateral sides (p.0.1, ANOVA; data not
shown).
Neurons in the ventromedial medulla retrogradely
labeled from the lumbar dorsal horn. After injections in
the L4–L6 dorsal horn, we counted in total 2334 retrogradely
labeled neurons (Figs. 3A and 4C). The majority of the
retrogradely labeled neurons was found ipsilateral to the
injection (RVM: 77%62; CVM: 67%610). Fig. 5B shows that
in the RVM the percentages of retrogradely labeled neurons
(ipsi+contra) that contained GAD67 was higher than the
percentages obtained for GlyT2 and GlyT2/GAD67 mRNA.
However, these differences were not significant (p.0.5, ANOVA).
In the CVM, there were also no significant differences between the
various percentages (p.0.1, ANOVA), but they were always
significantly lower than in the RVM (p,0.05, ANOVA). With
respect to the various percentages obtained for the ipsi and
contralateral side, there were no significant differences (p.0.05,
ANOVA; data not shown).
Neurons in the ventromedial medulla retrogradely
labeled from the lumbar ventral horn. After injections in
the L4–L6 ventral horn, a total of 3640 retrogradely labeled
neurons was analyzed (Figs. 3B and 4D, E). Most retrogradely
labeled neurons were found on the side ipsilateral to the injection
(RVM: 76%63; CVM: 51%616). The percentages of
retrogradely labeled neurons (ipsi+contra) that contained GlyT2,
GAD67, or GlyT2/GAD67 mRNA are depicted in Fig. 5C and
were always significantly lower in the CVM than in the RVM
(p,0.05, ANOVA). Within the RVM and the CVM, there were
no significant differences between the various percentages (p.0.1,
ANOVA, Fig. 5C) nor between the ipsilateral and contralateral
sides (p.0.1, ANOVA; data not shown), except that in the CVM
on the ipsilateral side 8%61 of the retrogradely labeled neurons
also contained GAD67, while significantly higher percentages
contained GlyT2 (19%63) and GlyT2/GAD67 (19%63) mRNAs
(p,0.05, ANOVA). This difference was not found on the
contralateral side.
Neurons in the Spinal Cord Retrogradely Labeled from
the Ventromedial Medulla
Injection sites. In this experiment, we analyzed retrogradely
labeled neurons in the spinal cord after injections of fluorescent
microspheres in the RVM area. We found that many of the
injection areas included the RM nucleus, the RP nucleus, and the
medial part of the LPGi nucleus and the Gi nucleus, and parts of
the pyramidal tract. After injections in the RVM that were limited
to the midline, fewer retrogradely labeled neurons were found in
the spinal cord (Fig. 6A). Further, when RVM tracer injections
were limited to one side only, we found that the majority of
retrogradely labeled neurons in the spinal cord were located on the
contralateral side (Fig. 6B).
Spinal distribution of the retrogradely labeled
neurons. Our results showed that the majority of the
retrogradely labeled neurons was located in the area around the
central canal (laminae X, and the adjoining medial parts of
laminae IV, V, VI, and VII), in the lateral part of lamina V and
the adjoining white matter including the lateral spinal nucleus
(LSN) (Fig. 6). Some retrogradely labeled neurons were also
present in lamina I. At all levels of the spinal cord that were
examined, i.e. the cervical (C4–C8), upper thoracic (T1–T5), low
thoracic (T10–T12), lumbar (L1–L6) and sacral (S1–S4) segments,
retrogradely labeled neurons that contained GlyT2/GAD67
mRNA were predominantly located in the area around the
central canal (Fig. 7), while very few double-labeled neurons were
present in the lateral parts of lamina V and the LSN (Fig. 6). On
average, 14%62 of the retrogradely labeled neurons in the grey
mater also contained GAD67 mRNA, 15%61 contained GlyT2
and 16%61 contained GlyT2/GAD67 mRNA. These
percentages were not significantly different (p.0.5, ANOVA).
Furthermore, we did not find significant differences between
various segmental areas in the spinal cord (p.0.5, ANOVA, data
not shown).
Discussion
In the present study, we have identified projection neurons in
the ventromedial medulla and the spinal cord using fluorescent
microspheres as a retrograde tracer. This technique is highly
Figure 3. The distribution patterns of neurons in the ventromedial medulla that were retrogradely labeled from the lumbar dorsal
or ventral horn. Drawings illustrating representative single brainstem sections of the rostral part of ventromedial medulla (RVM) and the caudal
part of ventromedial medulla (CVM). Black filled circles represent neurons retrogradely labeled with fluorescent microspheres from the lumbar dorsal
(A) or ventral (B) horn. Red filled triangles represent retrogradely labeled neurons that also contained GlyT2 and/or GAD67 mRNA (Gly/GABA). Note
that the caudal part of the CVM contains fewer retrogradely labeled neurons than the rostral part of the CVM, and that most retrogradely labeled Gly/
GABA neurons in both the CVM and RVM are located on the side ipsilateral to the injection. Gi: gigantocellular reticular nucleus, alpha part (GiA); IRt:
intermediate reticular nucleus, alpha part (IRtA); LPGi: lateral paragigantocellular reticular nucleus, alpha part (LPGiA), external part (LPGiE); LRt: lateral
reticular nucleus; Pn: pontine reticular nucleus, ventral part (PnV) and caudal part (PnC); Py: pyramid tract; Oi: olivary inferior nucleus; RMg: raphe
magnus; Tz: nucleus trapezoid body; 7Nuc: nucleus of seventh nerve; 1: raphe pallidus nucleus; 2: raphe obscurus nucleus; 3: raphe interpositus
nucleus.
doi:10.1371/journal.pone.0035293.g003
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Figure 4. Neurons in the ventromedial medulla that were retrogradely labeled from the spinal cord and neurons labeled for GlyT2
and/or GAD67 mRNAs. Fluorescence micrographs showing neurons in the ventromedial medulla retrogradely labeled with fluorescent
microspheres (red) from the spinal cord and neurons labeled for GlyT2 and/or GAD67 mRNA (green) using FISH. Arrowheads indicate GABAergic
(GAD67 mRNA containing) neurons in the caudal ventromedial medulla (CVM) retrogradely labeled from the cervical spinal cord (A); glycinergic
(GlyT2 mRNA containing) neurons in the rostral ventromedial medulla (RVM) retrogradely labeled from the cervical spinal cord (B); GlyT2 and/or
GAD67 mRNA containing neurons (Gly/GABA) in the RVM retrogradely labeled from the lumbar dorsal horn (C); Gly/GABA neurons in the RVM
retrogradely labeled from the lumbar ventral horn (D); Gly/GABA neurons in the CVM retrogradely labeled from the lumbar ventral horn (E). Scale
bar = 50 mm.
doi:10.1371/journal.pone.0035293.g004
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efficient for retrograde tracing as it is taken up by terminals rather
than by intact passing fibers [39]. The retrograde tracing was
combined with fluorescent in situ hybridization (FISH) using
probes for GlyT2 mRNA [36,40], GAD67 mRNA [41,42] and a
combination of these probes to separately identify glycinergic,
GABAergic and glycine and/or GABA containing (Gly/GABA)
neurons, respectively as described in our previous studies [29,30].
For each of the various injection sites (i.e. the cervical spinal cord,
the lumbar dorsal horn, the lumbar ventral horn and the RVM),
the percentages of the retrogradely neurons that were glycinergic,
GABAergic or Gly/GABA were not significantly different. We
therefore concluded that GABA and glycine coexist in the large
majority, if not all, of the retrogradely labeled neurons containing
either glycine or GABA, based on the reasoning that otherwise the
percentage of Gly/GABA neurons would have been significantly
higher. This conclusion is also in line with the extensive
colocalization of GABA and glycine in other regions of the
brainstem [37] and in the spinal cord [43,44], and the co-release of
GABA and glycine that was identified in lamina I of the spinal
cord [45]. Although the functional significance of the co-release of
GABA and glycine is still unclear, it seems most likely that the bulk
of fast synaptic inhibition is produced by glycine, while GABA is
involved primarily in negative feedback through presynaptic and
extrasynaptic sites [46]. In view of the extensive colocalization of
GABA and glycine, we will refer to these neurons as Gly/GABA
neurons in the remainder of the discussion.
We found that 29% of the neurons in the ventromedial medulla
projecting to the cervical cord were Gly/GABA, while these
percentages were 31% and 25% for the projections to the dorsal
and ventral horn, respectively. The high similarity of these
percentages may be explained by the high level of collateraliza-
tions that was found in the spinal projections from the
ventromedial medulla to the rostral and caudal parts of the spinal
cord, as well as the dorsal and ventral horns [2]. In addition to the
descending Gly/GABA projections, we also showed that there are
Gly/GABA neurons, predominantly located in the area around
the central canal throughout the spinal cord, with ascending
projections to the RVM. This finding is the first evidence for a fast
inhibitory spinal system, projecting to supraspinal levels.
Gly/GABA Projections from the Ventromedial Medulla to
the Dorsal Horn
For the identification of Gly/GABA neurons in the ventrome-
dial medulla that project to the dorsal horn, we have focused on
the lumbar cord, but in view of the high level of collateralization in
the ventromedial medullary projections to the spinal cord [2], they
are likely to hold true also for the other spinal segments. The
majority of the retrogradely labeled neurons were present in the
RVM and the rostral part of the CVM, which is in general
agreement with previous studies [2,47–49]. The percentage of
retrogradely labeled neurons that were Gly/GABA was higher in
the RVM (45%) than in the CVM (12%), showing that the
majority of the Gly/GABA projection neurons are located in the
RVM. The percentage of GABAergic neurons (56%) in the RVM
was higher than that of the glycinergic neurons (37%). Although
this difference was not significant, it may indicate that some of the
Figure 5. The percentages of neurons in the ventromedial
medulla that were retrogradely labeled from the spinal cord
and contained GlyT2 and/or GAD67 mRNAs. Histograms showing
the percentages of retrogradely labeled neurons in the ventromedial
medulla that contained GAD67, GlyT2, and GlyT2 and/or GAD67 mRNAs
after fluorescent microsphere injections in the cervical spinal cord (A),
in the lumbar dorsal horn (B) and in the lumbar ventral horn (C). The
percentages are shown separately for the caudal ventromedial medulla
(CVM) and rostral ventromedial medulla (RVM) and were always
significantly lower in the CVM than in the RVM (p,0.05). Differences
between the various percentages within the CVM and the RVM were
never significant (p.0.1).
doi:10.1371/journal.pone.0035293.g005
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RVM projections to the dorsal horn contain only GABA and not
glycine.
Previous studies, using retrograde tracing combined with GABA
immunohistochemistry (IHC) [18], GAD IHC [16,17] or ISH
[50], have shown that about 10–30% of the neurons retrogradely
labeled from the spinal cord were GABAergic. Anterograde
tracing from the RVM combined with GABA IHC at the
ultrastructural level [15] showed that 95% of the RVM derived
terminals in various laminae of the dorsal horn were GABAergic
(ascribed to the fact that the anterograde tracer was taken up
specifically by GABAergic neurons), with 12% of these terminals
also containing glycine. This latter finding is, so far, the only
anatomical evidence for a glycinergic projection to the dorsal
horn. Our findings now provide direct evidence for a glycinergic
projection to the dorsal horn, which is likely contained within the
GABAergic projection.
The RVM may facilitate or inhibit spinal nociception
depending on the type and the temporal-spatial characteristics of
the nociceptive stimulus [5,51]. The facilitatory effect of the RVM
is exerted by the physiologically characterized ON-cells, while the
inhibitory effect is mainly produced by the physiologically
characterized OFF-cells [3,5,52,53]. In the present study, we have
shown that about 45% of the neurons projecting to the spinal
dorsal horn are Gly/GABA, suggesting that glycine and GABA
are contained within the OFF-cells. Indeed, several studies have
shown the relation of RVM stimulation with antinociception
Figure 6. The distribution patterns of neurons in the spinal cord that were retrogradely labeled from the rostral ventromedial
medulla. Schematic drawings showing the brainstems of three rats with fluorescent microsphere injections (blue, purple and red) and the
corresponding spinal cords with the distribution of retrogradely labeled neurons (filled black circles), and retrogradely labeled spinal neurons also
containing GlyT2 and/or GAD67 mRNA (red triangles). Each segmental drawing, i.e. cervical (C4–C8), thoracic (T1–T3 and T10–T12), lumbar (L1–L6)
and sacral (S1–S4), shows the cumulative results obtained in 8-10 sections. Tracer injections were aimed at rostral ventromedial medulla (RVM) with
injections confined to the midline (purple), to one side only (blue), or both sides of the RVM (red). Note that tracer injections limited to the midline
yield fewer retrogradely labeled neurons in the spinal cord (purple), and injections limited to one side of the brainstem, yield more retrogradely
labeled neurons on the contralateral side of the spinal cord (blue as compared to purple and red). Roman figures indicate spinal laminae. LSN: lateral
spinal nucleus.
doi:10.1371/journal.pone.0035293.g006
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exerted by GABAergic and glycinergic neurotransmission in the
dorsal horn [54–57] and recently, a technically demanding study
on individual physiologically identified neurons [58], showed that
some OFF-cells were immunoreactive for GABA, although some
ON cells were positive as well. Taken together, there is strong
evidence that the GABAergic neurons in the ventromedial
medulla, many of which also contain glycine, are responsible for
the RVM inhibition of spinal nociception.
Gly/GABA Projections from the Ventromedial Medulla to
the Lumbar Ventral Horn
Microsphere injections in the lumbar ventral horn, which never
involved the dorsal horn, resulted in about equal numbers of
retrogradely labeled neurons in the RVM and the CVM as also
found in previous studies [2,49]. We found that several of the
retrogradely labeled neurons were Gly/GABA (RVM 35%, CVM
17%). The only studies on Gly/GABA projections to the ventral
Figure 7. Spinal neurons retrogradely labeled from the rostral ventromedial medulla, and spinal neurons labeled for GlyT2 and/or
GAD67 mRNAs. Fluorescence micrographs showing spinal neurons (red) retrogradely labeled with fluorescent microspheres from the rostral
ventromedial medulla (RVM) and spinal neurons (green) containing GlyT2 and/or GAD67 mRNA (glycinergic and/or GABAergic neurons) identified
with FISH. Arrowheads indicate spinal neurons in the area around the central canal, which are retrogradely labeled from the RVM and are also labeled
for GlyT2 mRNA in segment C5 (A) and for GlyT2 and/or GAD67 mRNAs in segments L5 (C) and L6 (B and D). Scale bar = 50 mm.
doi:10.1371/journal.pone.0035293.g007
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horn were performed in our lab previously, using anterograde
tracing from the ventromedial medulla to spinal motoneuronal cell
groups combined with GABA [19] or glycine [20] immunohisto-
chemistry at the ultrastructural level. These studies showed that
40% of the descending projections were GABAergic and 15%
were glycinergic. Our present retrograde findings, which also
include projections to the spinal intermediate zone, strongly
indicate that GABA and glycine are colocalized in the descending
projections to the ventral horn, suggesting that the finding of 15%
being glycinergic may be an underestimation. We found that a
relatively low percentage of spinally projecting neurons in the
CVM were Gly/GABA, which fits well with the recent finding
[59] that 61% of these neurons contain the vesicular glutamate
transporter 2, indicating they are glutamatergic.
With respect to the functional meaning of the descending Gly/
GABA projections from the ventromedial medulla, attention has
focused primarily on the question whether these Gly/GABA
projections are involved in producing muscle atonia during REM
sleep [1,60] or whether glutamatergic projections from the
ventromedial medulla induce motoneuronal inhibition through
inhibitory spinal interneurons. However, it seems likely that the
descending Gly/GABA projections may also be involved in
regulating motor activity during wakefulness, by modulating
somatomotor and visceromotor functions [61,62].
Gly/GABA Projections from the Spinal Cord to the RVM
For identifying the presence of a Gly/GABA projection from
the spinal cord to the RVM, several injections were made in the
RVM area. While the injection sites varied in size, the resulting
distribution pattern of retrogradely labeled neurons in the spinal
cord was always similar and in line with previous studies using
retrograde tracing from the RVM [28,63]. We found that many
neurons projecting to the RVM are located in the area around the
central canal (CC), and that about 15% of these projections
neurons are Gly/GABA. This pathway constitutes the only
projection from the spinal cord to a supraspinal structure (i.e.
the RVM area) with the fast inhibitory transmitters GABA and
glycine. Anterograde tracing from the CC area confirmed the
presence of direct projections, albeit limited, to the RVM [27].
Many neurons in the CC area have been identified to respond to
innocuous and noxious stimuli from the periphery and the viscera
[64–68], indicating an important role of the CC area in the
processing of sensory and especially visceral nociceptive informa-
tion. Whether the Gly/GABA neurons in the CC area respond to
peripheral and visceral noxious stimuli and whether the ascending
inhibitory projections are involved in inhibiting the spinal
projection neurons in the RVM is presently unclear.
Conclusions
The present study shows that many neurons in the ventromedial
medulla that project to the spinal cord contain both GABA and
glycine. It seems likely that the inhibitory projections to the dorsal
horn are involved in the inhibition of pain transmission, while the
projections to the ventral horn are likely involved in modulating
motor control during sleep and wakefulness. We also have shown
the existence of Gly/GABA containing spinal projection neurons,
originating mainly in the CC area and terminating in the RVM
area, emphasizing the complicated interaction between the
ventromedial medulla and the spinal cord. The extensive
projections of the ventromedial medulla to the spinal cord makes
it a very powerful system, possibly controlling the proper
homeostatic functioning of the entire organism [12]. Our study
has now definitely established that a substantial part of this system
uses glycine and GABA to exert its functions.
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